SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.39-0.6%9:57 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (8392)1/21/1999 7:32:00 AM
From: Robert K.  Read Replies (1) of 17367
 
There is a pertinent article in today NEJM about ideas to treat severe sepsis. As you know NEJM is well read. I cant read the article yet so I dont know if we will get a mention or not. Someone post if we do or dont.
Here is a recent listing of some therapies in trial
(not from todays article)
> Some therapeutic interventions in sepsis
undergoing clinical trials
Lipopolysaccharide analogues
High-density lipoprotein
Haemoperfusion with polymyxin B
Polymyxin B linked to dextran
Bactericidal permeability increasing protein
Anti-TNF antibodies
TNF receptor p55
Corticosteroids
Inhibitors of nitric-oxide (NO) synthase
Haemoglobin solutions (as NO scavengers)
Granulocyte-colony-stimulating factor
Antithrombin III, activated factor C, tissue-factor-pathway
inhibitor
Antioxidants (procysteine)
Immunonutrition (fish oil, antioxidants)
Lisofylline (anti-TNF agent)
Recombinant platelet-activating-factor inhibitor
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext